Novartis revenue by market 2023

Bitte beachten Sie, dass die von Ihnen aufgerufene Seite nicht in Ihrer Standardsprache vorliegt. Sie nutzen unsere Plattform nun in einer anderen Sprache.

This statistic reflects Novartis AG's revenue in 2023, distributed by market. Swiss-based Novartis AG is one of the largest global pharmaceutical companies. In that year, the company generated 73 percent of its revenues in established markets and some 27 percent in emerging markets.

Percentage of Novartis AG's revenue in 2023, by market

Characteristic	Percentage of total segment revenue
Established markets	74%
Emerging growth markets	26%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

January 2024

More information

Region

Worldwide

Survey time period

2023

Supplementary notes

Net sales from continuing operations by location of customer. Emerging growth markets comprise all markets other than the established markets of the US, Canada, Western Europe, Japan, Australia and New Zealand. Novartis definition of Western Europe includes Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, The Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.
Percentages calculated based on given sales figures.

Citation formats